IGM Biosciences Inc. (IGMS)
NASDAQ: IGMS
· Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 13, 2025, 3:59 PM
0.00% (1D)
| Bid | 1.25 |
| Market Cap | 77.5M |
| Revenue (ttm) | 145.05M |
| Net Income (ttm) | -53.38M |
| EPS (ttm) | -0.9 |
| PE Ratio (ttm) | -1.41 |
| Forward PE | -0.91 |
| Analyst | Hold |
| Ask | 1.29 |
| Volume | 1,588,637 |
| Avg. Volume (20D) | 634,437 |
| Open | 1.27 |
| Previous Close | 1.27 |
| Day's Range | 1.27 - 1.27 |
| 52-Week Range | 0.92 - 22.50 |
| Beta | 0.59 |
About IGMS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IGMS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IGMS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
IGM Biosciences Inc. is scheduled to release its earnings on
Nov 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+15.18%
IGM Biosciences shares are trading higher after th...
Unlock content with
Pro Subscription
7 months ago
-66.29%
IGM Biosciences shares are trading lower after the company announced it is halting further development of Imvotamab and IGM-2644.
